ARCHIVES

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

This article is from The Cancer Letter archive.

Vol. 02 No. 40 | October 1, 1976

Download PDF Visit The Full Archive

Related Articles

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

December 31, 2010

Expiring Program Offer Flexibility

February 12, 1982

In Brief: O’Brien Will Leave USC To Become Medical School Dean At Creighton; DRCCA Adds New Staff Members

May 14, 1982

DeCosse: Colorectal Screening Could Save 6,000 Lives Per Year

November 29, 1991

Mayo’s Regional Program – Keys To Success Are Service, Communications

December 9, 1977

ACS Seeks Applications For Clinical Awards

January 1, 1993